World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
35727
World Ranking
8912
National Ranking
4585

Overview

Joachim Yahalom is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on medicine, contributing extensively to subfields such as pathology and forensic medicine, oncology, neurology, pulmonary and respiratory medicine, and radiology, nuclear medicine, and imaging.

The scientist's work covers key topics including lymphoma diagnosis and treatment, CAR-T cell therapy research, CNS lymphoma diagnosis and treatment, lung cancer treatments and mutations, viral-associated cancers and disorders, chronic lymphocytic leukemia research, and integrated circuits and semiconductor failure analysis.

Yahalom has published frequently in several respected publication venues, with the highest number of publications in Blood, Hematological Oncology, and the International Journal of Radiation Oncology*Biology*Physics. Additional venues include Blood Advances and the Journal of Clinical Oncology.

Recent notable papers include:

  • Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma, 2021, Journal of Clinical Oncology
  • Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology, 2020, Journal of the National Comprehensive Cancer Network
  • Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines, 2020, International Journal of Radiation Oncology*Biology*Physics
  • Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making, 2020, Leukemia
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies, 2020, Blood Advances

Frequent coauthors in Yahalom's research include Brandon S. Imber, Gilles Salles, Andrew D. Zelenetz, Carla Hajj, and Alison J. Moskowitz.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

    Daniel J. Klionsky;Hagai Abeliovich;Patrizia Agostinis;Devendra K. Agrawal

  • A Novel Response of Cancer Cells to Radiation Involves Autophagy and Formation of Acidic Vesicles

    Shoshana Paglin;Timothy Hollister;Thomas Delohery;Nadia Hackett

  • Treatment for Primary CNS Lymphoma: The Next Step

    Lauren E. Abrey;Joachim Yahalom;Lisa M. DeAngelis

  • Long-term survival in primary CNS lymphoma.

    Lauren E. Abrey;Lisa M. DeAngelis;Joachim Yahalom

  • Combined modality therapy for primary CNS lymphoma.

    Lisa M. DeAngelis;Joachim Yahalom;Howard T. Thaler;Uma Kher

  • Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model

    Lauren E. Abrey;Leah Ben-Porat;Katherine S. Panageas;Joachim Yahalom

  • Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).

    Lena Specht;Joachim Yahalom;Tim Illidge;Anne Kiil Berthelsen

  • Superior Vena Cava Syndrome with Malignant Causes

    Lynn D. Wilson;Frank C. Detterbeck;Joachim Yahalom

  • A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

    Craig H. Moskowitz;Stephen D. Nimer;Andrew D. Zelenetz;Tania Trippett

  • Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

    Tarun Kewalramani;Andrew D. Zelenetz;Stephen D. Nimer;Carol Portlock

  • Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

    Patrick G. Morris;Denise D. Correa;Joachim Yahalom;Jeffrey J. Raizer

  • How I treat extramedullary acute myeloid leukemia

    Richard L. Bakst;Martin S. Tallman;Dan Douer;Joachim Yahalom

  • Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma

    Gaurav D. Shah;Joachim Yahalom;Denise D. Correa;Rose K. Lai

  • Non-Hodgkin's Lymphomas

    Andrew D. Zelenetz;Ranjana H. Advani;John C. Byrd;Myron S. Czuczman

  • Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma

    Craig H. Moskowitz;Joseph R. Bertino;Jill R. Glassman;Eric E. Hedrick

  • NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.

    Zelenetz Ad;Abramson Js;Advani Rh;Andreadis Cb

  • Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone.

    Naomi R. Schechter;Carol S Portlock;Joachim Yahalom

  • Long-Term Follow-Up of High-Dose Methotrexate-Based Therapy With and Without Whole Brain Irradiation for Newly Diagnosed Primary CNS Lymphoma

    Igor T. Gavrilovic;Adília Hormigo;Joachim Yahalom;Lisa M. DeAngelis

  • Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy.

    L M DeAngelis;J Yahalom;M H Heinemann;C Cirrincione

  • Intensity-modulated tangential beam irradiation of the intact breast

    L Hong;M Hunt;C Chui;S Spirou

Frequent Co-Authors

Andrew D. Zelenetz
Andrew D. Zelenetz Memorial Sloan Kettering Cancer Center
Craig H. Moskowitz
Craig H. Moskowitz University of Miami
David J. Straus
David J. Straus Memorial Sloan Kettering Cancer Center
Richard T. Hoppe
Richard T. Hoppe Stanford University
Lena Specht
Lena Specht University of Copenhagen
Lisa M. DeAngelis
Lisa M. DeAngelis Memorial Sloan Kettering Cancer Center
Ranjana H. Advani
Ranjana H. Advani Stanford University
Louis S. Constine
Louis S. Constine University of Rochester Medical Center
Heiko Schöder
Heiko Schöder Memorial Sloan Kettering Cancer Center
Leo I. Gordon
Leo I. Gordon Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the medical field in the USA offers diverse career paths beyond the traditional MD route. Many students are drawn to nursing and allied health studies due to their strong job outlook and flexible entry points. For those interested in academic and leadership roles, an online phd nursing program can open doors to advanced research and teaching opportunities.

If you're already a registered nurse, upgrading your qualifications through one of the most affordable accredited online rn to bsn programs can be a cost-effective way to boost your credentials and career prospects. For non-nursing graduates keen to enter this rewarding field, options like direct entry msn programs offer an accelerated path to becoming a registered nurse with a master’s degree.

Students looking for more accessible entry points often consider what is the easiest nursing program to get into. This can be helpful for applicants who want to start their healthcare career quickly. Exploring these different online study options allows aspiring medical professionals to find flexible pathways suited to their goals and backgrounds.

Best Scientists Citing Joachim Yahalom

Trending Scientists

Recently Published Articles